Novaremed raised €127M in a funding round in Jul 2022. The company is based in Basel, Switzerland. Investors in the round: NeuroFront Therapeutics. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
